Evidence map›Paper›PMID 42369691›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026

[Clinical Study of Robotic Natural Orifice Specimen Extraction Surgery for Right Colon Cancer].

Dongning Liu, Ruichen Zhou, Feng Xiao, Wenjun Hu, Penghui He, Gengmei Gao, Yahang Liang, Taiyuan Li

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dongning Liu（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.ORCID 0000-0003-1419-0055
Ruichen Zhou（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Feng Xiao（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Wenjun Hu（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Penghui He（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Gengmei Gao（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Yahang Liang（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Taiyuan Li（ 330006）Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.ORCID 0000-0001-9492-1545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the safety and feasibility of robotic natural orifice specimen extraction surgery (NOSES) for right colon cancer. Methods: Twenty-two female patients undergoing this procedure between January 1, 2022 and January 31, 2025 were enrolled. Safety and feasibility were assessed by analyzing operative time, intraoperative blood loss, conversion rate to open surgery, postoperative complications, 30-day mortality, and 30-day unplanned surgery-related readmission rate. Results: All procedures were completed successfully. The median operative time was 158 min (152-169 min), and the median blood loss was 53 mL (43-75 mL). No conversions to open surgery occurred. The first postoperative flatus occurred at a median of 53.00 h (49.25-57.50 h), and the median postoperative hospital stay was 9.00 d (8.00-11.00 d). Postoperative complications included one case of intestinal obstruction. No anastomotic leakage, anastomotic bleeding, vaginal hemorrhage, vaginal infection, or abdominal infection was observed. There were no deaths within 30 days and no unplanned surgery-related readmissions. Conclusion: Robotic NOSES for right colon cancer is safe and feasible.

Indexed as

Colonic NeoplasmsNatural Orifice Endoscopic SurgeryRobotic Surgical ProceduresAgedBlood Loss, SurgicalFeasibility StudiesFemaleHumansMiddle AgedOperative TimePostoperative ComplicationsNatural orifice specimen extraction surgeryRight colon cancerRobotic surgery

Identifiers

PMID42369691
PMCPMC13303227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.